Covered recipient · General Payments record
HARISH GANGARAM AHUJA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$27,103.98
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,200.00 | 1 |
| Food and Beverage | $1,327.70 | 47 |
| Travel and Lodging | $1,044.49 | 4 |
| Education | $99.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| TAIHO ONCOLOGY, INC. | $3,456.57 | 14 |
| Merck Sharp & Dohme Corporation | $192.80 | 5 |
| Tempus AI, Inc | $148.02 | 5 |
| AVEO Pharmaceuticals, Inc. | $130.97 | 2 |
| Daiichi Sankyo Inc. | $113.50 | 1 |
| Acerta Pharma LLC | $60.54 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $60.24 | 3 |
| Deciphera Pharmaceuticals Inc. | $59.86 | 2 |
| ARRAY BIOPHARMA INC | $56.01 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $49.00 | 2 |
| PFIZER INC. | $47.73 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $47.15 | 2 |
| Regeneron Healthcare Solutions, Inc. | $35.55 | 1 |
| Kite Pharma, Inc. | $33.38 | 1 |
| GlaxoSmithKline, LLC. | $26.16 | 1 |
| ADC Therapeutics America, Inc. | $25.22 | 1 |
| Janssen Biotech, Inc. | $24.77 | 1 |
| E.R. Squibb & Sons, L.L.C. | $22.45 | 1 |
| EISAI INC. | $21.85 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.53 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $19.56 | 1 |
| Genmab U.S., Inc. | $19.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.